Cargando…
Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
Cysteine proteinase cathepsin S (Cat S) is expressed mainly in lymphatic tissues and has been characterised as a key enzyme in major histocompatibility complex class II (MHC-II) mediated antigen presentation. Cat S has been measured in tissue cytosols of lung parenchyma, lung tumours and lymph nodes...
Autores principales: | Kos, J, Sekirnik, A, Kopitar, G, Cimerman, N, Kayser, K, Stremmer, A, Fiehn, W, Werle, B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375152/ https://www.ncbi.nlm.nih.gov/pubmed/11710834 http://dx.doi.org/10.1054/bjoc.2001.2057 |
Ejemplares similares
-
Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
por: Schweiger, A, et al.
Publicado: (2000) -
Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients
por: Werle, B, et al.
Publicado: (1999) -
Primary tumour characteristics and axillary lymph node status in breast cancer
por: Yiangou, C, et al.
Publicado: (1999) -
Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma
por: Leusink, Frank K., et al.
Publicado: (2018) -
Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
por: Berney, D M, et al.
Publicado: (2001)